CLDN10, a glandular epithelial marker in epithelial ovarian cancer (Seo et al., 2010), was reported to be a key immune-related gene in clear cell renal cell carcinoma (Yang et al., 2021) and papillary thyroid carcinoma (Xiang et al., 2020). This evidence concerns the gene CLDN10 and thyroid gland papillary carcinoma.